Advertisement

More deaths, no benefit from malaria drug in VA virus study

This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. According to a study released on Tuesday, April 21, 2020, the malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in an analysis of its use in U.S. veterans hospitals. There were more deaths among those given hydroxychloroquine versus standard care, researchers report. (AP Photo/John Locher)
This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. According to a study released on Tuesday, April 21, 2020, the malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in an analysis of its use in U.S. veterans hospitals. There were more deaths among those given hydroxychloroquine versus standard care, researchers report. (AP Photo/John Locher)(KGWN)
Published: Apr. 21, 2020 at 3:46 PM CDT
Email this link
Share on Pinterest
Share on LinkedIn

A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large new study.

Researchers reported there were more than twice as many deaths among patients getting hydroxychloroquine than usual care. The analysis involved 368 men with COVID-19 in U.S. veterans hospitals.

Although it was not a rigorous experiment, it is the biggest report of results so far for the drug, with or without the antibiotic azithromycin, against the coronavirus.

The analysis was posted on an online site for researchers, but has not been reviewed by other scientists.

Latest News

Latest News